chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain and weakness in arm for almost 5 days.  vertiginous migraine started within 12 hours, and lasted four weeks and three days, 24 hours a day, This is the longest vertigo episode I have had in my life ( longest was 3 weeks).  Prior to this,  I had not had a vertigo episode for over a year!  It made me exhausted and I had a few headaches from the vertigo itself. There is no effective treatment for it.  After two weeks, I decided to try an essential oil blend- topically and internally, which I made specifically to manage vertigo.  Internally, I placed frankincense on the roof of my mouth and took Zendocrine blend supplements.  This all helped significantly, yet this major vaccine side effect lasted incredibly long. I could not work, drive, or walk safely. I heard that for some people, the vaccine triggered underlying illnesses or "weak spots." I figured that's what happened to me. Last day of vertigo was May 14. It took another week to bounce back, still felt pretty tired until May 21. Finally think I am recuperated.  For the first vaccine, I had a major migraine within 24 hours, arm pain for 3 days, and needed a nap in the middle of the day. It was very mild and easy compared to the second vaccine dose.  Prior to vaccination, I called my PCP and MCS, and both Doctors told me I was cleared to take the vaccine, and did not think I would have any issues with it.
Initial report received from a healthcare professional on 24 OCTOBER 2014. A 63-year-old male patient, whose medical history was reported as unknown and concomitant medication were not reported, had received intramuscularly a dose FLUZONE QIV, (batch number: UI192AA, expiry date: 30-JUN-2015) and cycle in series not reported, in left deltoid on an unspecified date. On an unspecified date, patient experienced earache, headache, body aches and arm was painful and has also experienced "not feeling right". Illness at the time of vaccination was not reported. Corrective treatment and laboratory investigations were not reported.  At the time of this report, the outcome of the event was reported as not recovered. Documents held by sender; none. Follow up information received from a health care professional on 6 FEBRUARY 2015. It was reported that patient had no concomitant medications and his medical history was reported as none, it was also reported that patient had not received any previous dose of FLUZONE QIV. The patient had received the vaccine on 15 OCTOBER 2014. Onset date of events was reported as 16 OCTOBER 2014. The patient had recovered on an unspecified date.
Three days after imz, patient had rash on arm/bumps and arm was hot.  She used topical diphenhydramine and took one acetaminophen
Rash on upper arm, above elbow, red, swelling and pt. fill heat. May be cellulitis.
lethargic; body ache; He cannot raise his arm very high; pain in the injection area; fever; This spontaneous case was reported by a patient and describes the occurrence of LETHARGY (lethargic), PAIN (body ache), VACCINATION SITE MOVEMENT IMPAIRMENT (He cannot raise his arm very high), VACCINATION SITE PAIN (pain in the injection area) and PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: FLU vaccine (He had felt like he got the flu with flu vaccines in the past.), COVID-19 vaccine (Dose 2, He did not had a reaction this bad with previous doses), COVID-19 vaccine (Dose 1 and He did not had a reaction this bad with previous doses). Past adverse reactions to the above products included Influenza like illness with FLU vaccine; and Vaccination adverse reaction with COVID-19 vaccine and COVID-19 vaccine. Concurrent medical conditions included Agoraphobia (He had fairly severe agoraphobia and does not leave the house often.).    On 25-Oct-2023 at 5:30 PM, the patient received third dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. In October 2023, the patient experienced LETHARGY (lethargic), PAIN (body ache), VACCINATION SITE MOVEMENT IMPAIRMENT (He cannot raise his arm very high), VACCINATION SITE PAIN (pain in the injection area) and PYREXIA (fever). The patient was treated with IBUPROFEN in October 2023 for General body pain, at an unspecified dose and frequency. At the time of the report, LETHARGY (lethargic), PAIN (body ache), VACCINATION SITE PAIN (pain in the injection area) and PYREXIA (fever) had not resolved and VACCINATION SITE MOVEMENT IMPAIRMENT (He cannot raise his arm very high) outcome was unknown.            It was reported that patient did not receives any other vaccines 4 weeks prior to COVID-19 vaccine.  Concomitant product use was not provided by the reporter.  Patient receives his third covid-19 vaccine on 25-Oct-2023 around 5:30 P.M.  It was reported that he had pain in the injection area that was pretty severe. He could not raise his arm very high. He was also feeling lethargic, fever, body aches really bad. He had taken ibuprofen for his body aches.   Reporter did not allow further contact
Fever (100.6), headache, joint paint and stiffness, fatigue, stomach upset, ringing in my ears. Fever treated with Tylenol-type pain med, bed rest. Fever broke to normal in 24 hours, other symptoms lessened over two days, headache and joint stiffness continues to 2/5/19.
Patient recieved influenza vaccination on 12-21-2007 Sanofi U2509AA 06-30-2008 in the R deltoid. Good site location was noted when complaint was stated.  Pt. c/o of local site pain/discomfort on 01-22-2008.  Client stated that after 2-3 weeks of injection pt. presented to same clinic and saw LVN and stated she still had site pain and discomfort with movement that radiated to the tricep area on the right arm.  LVN told her to stop taking ASA and start taking acetaminophen for the discomfort/pain.  No report was filed to lead nurse at the time.  On 01-22-2008 pt presented to R.N. and restated symptoms with c/o of "lightening pain" when she lifts her right arm over the height of her shoulder.  Client has no insurance and wants pmd evaluation.  I directed her to my supervisor with instructions to file her complaints/expectations in writing with a copy of a picture her husband took 2 weeks after the injection, ASAP.  I also gave her my supervisor name/address/phone, my name, nurses names.  I asked if she had tried any NSAIDs for the discomfort and asked if she has any allergies/stomach ulcers/liver or kidney disease.  She stated no, I recommended ibuprofen 200mg tabs ii po q8hrs x 3 days with meals and outlined possible stomach problems that may occur and to stop if they occur. I also stated that if no relieve or lessing of discomfort was noted after 3 days to stop the NSAIDs. pt. stated understanding and left with that information. The next day I called the immunization coordinator for the county and left a message for her to contact me regarding this patient then I completed the VAERS form via email while I awaited her response.
Incorrect dose was given for this patients age.  Was given Meningococcal B, Should have been given Meningococcal Conjugate Valent 4 (MCV).  Patient had no adverse reaction to the vaccine given.
Received a flu vaccination on 10-29-07 and reported that the site of the injection was red, swollen and very tender for approx. 5 days.  Resolved without seeing a health care provider.
Muscle is spasming, forward cone of pain, numbness from injection site to back of elbow.
Large area of redness and warmth of right arm consistent with cellulitis or infection of skin.
Sore Arm; Headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm) and HEADACHE (Headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore Arm) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Sore Arm) and HEADACHE (Headache) was resolving.            Concomitant Medication was not provided. Treatment Medication was not provided. patient is feeling fine now.   This case was linked to MOD-2021-237491 (Patient Link).
MODERNA COVID VACCINE #3 GIVEN 3/9/22, LOT #003J21-2A; 3/15/22 pt to ED in cardiac arrest, PEA; ROSC achieved after arrival to ED; intubated and sedated; septic shock, UTI, chronic sacral ulcer infection, positive for COVID; started on ABX and dexamethasone; concern for anoxic brain injury; poor neurological prognosis; family chose to withdraw care and pt expired in the hospital
Patient came in on 10/11/2019 with rx for anti-inflammatory and stated that she just wanted to make us aware of an adverse effect she had after receiving her vaccinations the month prior.  She stated that within a couple hours of getting her shots on 9/17/2019, she began experiencing limited mobility in her shoulder and increasing pain.  She made an appointment with her physician on 10/11/2019 who stated that he believed her pain and discomfort was a result of the vaccine being given too high in her shoulder and into her bursa.  He prescribed her an antiinflammatory and told her to move her shoulder as much and often as possible and estimated her full heal time as a couple months.
I had an A-fib issue that started last year 2020.  Dr. said the vaccine said it could have some affect on my. My phone tracks heart rate volatility  and it's usually around 50 to 100 and since the vaccine it has increased to - 100 -200  with volatility. It's still elevated and I have been taking blood thinner  - Zerelcoan and another medication  - amiodarone that is suppose to help. calls to doctor. It hasn't I will be having a cardioversion tomorrow which hopefully it will be putting it back in rhythm.
Discomfort in Chest prolonging for 3+ days. Hard and swollen lymph node on the left jaw line, abnormal shooting headache, serious fatigue, nausea, dizziness.
some body aches woke him up in the middle of the nigh but then felt fine; some body aches; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (some body aches woke him up in the middle of the nigh but then felt fine) and MYALGIA (some body aches) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A, 006B21A and 058H21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INSOMNIA (some body aches woke him up in the middle of the nigh but then felt fine) and MYALGIA (some body aches). At the time of the report, INSOMNIA (some body aches woke him up in the middle of the nigh but then felt fine) and MYALGIA (some body aches) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment medication use was reported.   This case was linked to MOD-2021-399916 (Patient Link).
I26.99 ACUTE PULMONARY EMBOLISM 5/3/2023 DYSPHAGIA J96.00 ACUTE RESPIRATORY FAILURE 5/3/2023 DYSPHAGIA J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 4/4/2023 DYSPHAGIA R09.02 HYPOXIA 5/3/2023 DYSPHAGIA I26.99 ACUTE PULMONARY EMBOLISM 5/3/2023 DYSPHAGIA J96.00 ACUTE RESPIRATORY FAILURE 5/3/2023 DYSPHAGIA J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 4/4/2023 DYSPHAGIA R09.02 HYPOXIA 5/3/2023 DYSPHAGIA
Symptoms: nasopharyngeal itching and swelling bilateral eyelids swelling. Treatment: ZYRTEC 10 mg oral once daily (x 10 days), Prednisone 10mg oral once daily (x 10 days).
Patient reported history of reaction with vaccine in past. 2 vaccines were administered in the same arm per patient request. Patient was monitored in the pharmacy area for 15 minutes post-vaccination with no reaction. Patient left the pharmacy area. In the evening, patient reported they had swelling of the arm. The following day, patient reported they had additional arm swelling and throat swelling with difficulty breating, when they went to the emergency room. Patient was admitted to hospital and treated for vaccine reaction, and discharged two days later.
Facial swelling noted approximately 24 hours after the first injection was administered.  Oral Benadryl administered upon onset of symptoms.  Prescribed medication treatment resolved the adverse reaction.
enlarged lymph nodes; felt achy; sore arm; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 28Jan2021 15:15 (Lot number: EI9262) at the age of 48 years as dose 1,single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 05Feb2021 15:00, outcome "recovered with sequelae" (07Feb2021), described as "enlarged lymph nodes"; PAIN (non-serious) with onset 05Feb2021 15:00, outcome "recovered with sequelae" (07Feb2021), described as "felt achy"; PAIN IN EXTREMITY (non-serious) with onset 05Feb2021 15:00, outcome "recovered with sequelae" (06Feb2021), described as "sore arm". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (08Mar2021) negative. Therapeutic measures were not taken as a result of lymphadenopathy, pain, pain in extremity.  Additional information: Facility type vaccine was in hospital. The patient did not receive any other vaccine in four weeks. The patient had not covid prior vaccination. The patient had covid tested post vaccination.   No follow-up attempts are possible. No further information is expected
Child received Boostrix shot on 7/13/06. On 7/21/06 child suffered a generalized tonic clonic activity seizure. The entire event lasted for 3-5 minutes. Parents found him moaning and foaming from the mouth, up-rolling of eyes, moaning sounds and generalized tonic clonic activity. The event lasted for 3-5 minutes. He was visiting out of state at the time and was taken by EMS to a local medical center. EMS reported that he was still disoriented and could not tell his age when they arrived. He was also afebrile. Tests included a CBC, CMP, and CT of the head. All were reported normal.  He was also seen by a Pediatric Neurologist on July 25th. Dr saw him and reported his neurological exam to be normal. He performed a sleep-deprived EEG which was also read as normal. An MRI was ordered (pending at time of report). The child was prescribed Diastat 15mg prn to use if reocurence of his seizures happens.   Did receive the series as infant and at age 5 received DTaP. No reactions reported.
Developed 15 cm x 9 cm area (oval) of erythema w/minimal edema, no bagginess or tenderness. Brought to ER 1/23/16, and diagnosed w/cellulitis. See in office 1/25/16, diagnosed w/localized reaction to imms, no evidence of further ER visits.
Patient reports rash to chest areas (rash is localized) with no itching or flushing .  Patient reports symptoms started after 15 minutes observation and on her home from vaccination site. Patient was advised to go to urgent care/ER but refused.  She was seen and cleared by on-site EMS.  BP 185/103, HR 70, SPO2 100%.  Patient refused to go to ER as advised by EMS personnel.  She stated she wanted to watch It [rash] and see if it will resolve on its own.
A non-serious report was received from a physician of VACCINE EXPOSURE DURING PREGNANCY concerning a 16-year-old female.  No medical history or concomitant medications were reported for this patient.  On 19 Dec 2007, the patient was accidentally administered a FLUMIST vaccine.  The patent was 28 weeks gestation at the time, and the reporter indicated that the patient had no experienced any problems.  No further information was provided.  The pregnancy is ongoing.  Rechallenge is not applicable.  The reporter did not provide a causality statement for the event.  The reporting source of this case is spontaneous, thus the sponsor's comment is not applicable.
Pt recvd OPV/HIB/DTP/Engerix-B & w/in 30 sec pt turned pale, limp; HR 120, 4 mins BP 40/?; MD felt porbably vagal spell secondary to pain, fainting, bradycardia & not true hypotension secondary to pertussis vax;
A literature abstract has been received from a health professional. The report concerns a retrospective chart review of a 42-year-old female patient of unknown ethnic origin. No medical history was reported. No concomitant products were reported. On an unknown date, Two days after the administration of the influenza virus vaccine live, (intranasal), the patient presented with pain, redness, tearing, and discomfort in both eyes. Examination of the eyelids was unremarkable in both eyes. Anterior segment examination of the both eyes showed conjunctival hyperemia, and several corneal sub-epithelial peripheral infiltrates separated from the limbus by a clear zone. Anterior chamber and posterior segments were unremarkable in both eyes. It was diagnosed as a hypersensitivity reaction, which manifests in the form of marginal keratitis. The condition resolved with topical antibiotics and corticosteroids. It was unknown if any action was taken with influenza virus vaccine live, (intranasal). The patient recovered from the event(s) of bilateral marginal keratitis and hypersensitivity reaction on an unspecified date. The events were considered serious (important medical event). The reporter considered the following event(s) related to treatment with influenza virus vaccine live, (intranasal): hypersensitivity reaction and bilateral marginal keratitis. The authors commented: "Ocular complications of vaccines are rare. Intranasal live-attenuated influenza virus vaccine may trigger a hypersensitivity reaction, which manifests in the form of marginal keratitis. To the best of our knowledge, this is the first report of such complication after the administration of an influenza virus vaccine." Sender's Comments: Bilateral marginal keratitis is not listed in the company core data sheet for intranasal live-attenuated influenza virus vaccine. The event occurred 2 days after the administration of the suspect vaccine. The listed event of Hypersensitivity could be possibly confounding. Due to missing information on exact administration dates of the suspect vaccine with indication and dose, exact event onset date, underlying comorbidities, relevant medical history, concomitant medication, further diagnostic workup it is not possible to make a conclusive assessment of the causal relationship of event and suspect vaccine. Follow up information is being requested to make the case more complete and enable the assessment of the relationship.
Case number PHEH2014US025148, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 29 year old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 28 Oct 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was in between 46 to 49 degree F during excursion. No adverse events reported after the maladministration.
left arm pit pain that started 4/16/21, overnight into 4/17/21 started with some swelling above left collar bone that feels fluid filled and about the size of an egg
I received my Pfizer booster for COVID-19 on 8/19/2021. On 6/28/2022, I woke up with symptoms that included mild dizziness, mild headache, a low-grade fever, and a cough. I took an at-home test for COVID-19 that morning, and the result was positive. I called my doctor's office, and he arranged for me to receive monoclonal antibodies, which I received 7/1/2022. I was also given an antibiotic, though I do not remember the name of it. My symptoms lasted for only about 5 days, but I continued to test positive for about 2 weeks. During this time, I just self-isolated. I finally tested negative about 7/12/2022.
Head pressure began 4 days after 2nd dose and continue to persist today (45 days) after 2nd dose. The head pressure causes dizziness. The head pressure sometimes is mostly on the left side and shifts to sinus pressure and left ear pressure. When the head pressure shifts to sinus and ear pressure, dizziness subsides. The head pressure almost everyday but there were a few days where the the pressure subsided. Took zyrtec for 4 weeks but had no effect. Took flonase for 1 week and had no effect. Sudafed sometimes helps relieve pressure for a few minutes but it persists soon after.
He was sitting on a chair for 15 mins, and around 14 mins he felt light headed and rolled over from the chair. He came back after 15-30 seconds and felt dizzy. We unbuttoned his pants and let him sit for 30 mins and had some water. After 30 mins, he had little numbness on his arm but he felt fine.
His arm always get a little sore after receiving a vaccine/felt something in his arm; Felt something in his arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (His arm always get a little sore after receiving a vaccine/felt something in his arm) and LIMB DISCOMFORT (Felt something in his arm) in a 68-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Patient had no allergies, had No covid test or diagnosis and patient had no Acute and Chronic illnesses at the time of vaccination.  Concurrent medical conditions included Blood pressure high.    On 30-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (His arm always get a little sore after receiving a vaccine/felt something in his arm) and LIMB DISCOMFORT (Felt something in his arm). At the time of the report, PAIN IN EXTREMITY (His arm always get a little sore after receiving a vaccine/felt something in his arm) and LIMB DISCOMFORT (Felt something in his arm) had resolved.            Patient did not receive any other vaccines within 1 month prior to Moderna COVID-19 vaccine.  No concomitant medications were reported.   It was reported that the patient had received the Bivalent Booster and it was the best one. Patient arm always get a little sore after receiving a vaccine. Patient doesn´t believe this was a side effect at all, he said that he felt something in his arm because of the injection and patient feels this with every vaccine that he receives.  No treatment details were reported.
nausea devel 1JUL94 12AM; achy joints, fever on/off up to 102.6 1JUL-7JUL; h/a
fever, jerking (all extr) w/tremors, drooling-3-4 mins; limp 10-15 mins afterward; ?eye deviation to rt to ER also had onset of diarrhea; no tx rendered in ER; EEG set for next week;